Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | BCHE | P06276 | 6/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | HTR2C | P28335 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6970049 | 0.78 | L3MBTL1 (0.54) | MAPK1SMN1; SMN2L3MBTL1POLBGAA | |
| SCHEMBL11574280 | 0.77 | SMN1; SMN2 (0.54) | MAPK1SMN1; SMN2L3MBTL1CYP3A4CYP1A2 | |
| SCHEMBL11574947 | 0.77 | MAPK1 (0.54) | MAPK1SMN1; SMN2L3MBTL1MEN1KMT2A | |
| SCHEMBL11574197 | 0.77 | SMN1; SMN2 (0.54) | MAPK1SMN1; SMN2L3MBTL1KMT2ACYP1A2 | |
| SCHEMBL10306784 | 0.75 | NOX1 (0.44) | MAPK1L3MBTL1BCHEMEN1CYP3A4 | |
| SCHEMBL7819239 | 0.74 | MAPK1 (0.49) | MAPK1SMN1; SMN2L3MBTL1KMT2ASLC6A2 | |
| SCHEMBL2151191 | 0.72 | MAPK1 (0.77) | MAPK1SMN1; SMN2L3MBTL1HTR2A | |
| SCHEMBL8200284 | 0.72 | MAPK1 (0.47) | MAPK1SMN1; SMN2L3MBTL1MEN1CYP3A4 | |
| SCHEMBL8286780 | 0.71 | BCHE (0.41) | MAPK1BCHEMEN1CYP3A4KMT2A | |
| SCHEMBL19154335 | 0.71 | CHRM3 (0.49) | MAPK1SMN1; SMN2L3MBTL1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017121755-A1 | ZUCLOPENTHIXOL HYDROCHLORIDE DERIVATIVES AND EBSELEN DERIVATIVES AS ERBB2 INHIBITORS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2017-07-20 | — | — | WO | disclosed |
| EP-0738262-B1 | NOVEL HETEROCYCLIC COMPOUNDS | NOVO NORDISK AS (DK) | 2000-04-19 | — | — | EP | disclosed |
| US-6043239-A | N-SUBSTITUTED AZAHETEROCYCLIC CARBOXYLIC ACIDS AND ESTERS THEREOF IN WHICH A SUBSTITUTED ALKYL CHAIN FORMS PART OF THE N-SUBSTITUENT; TREATMENT OF PAINFUL, HYPERALGESIC AND/OR INFLAMMATORY CONDITIONS | NOVO NORDISK A/S (DK) | 2000-03-28 | — | — | US | disclosed |
| WO-2000006552-A1 | 4-PHENYL- AND 4,5-DIPHENYLIMIDAZOLE DERIVATIVES, PREPARATION AND THERAPEUTIC APPLICATION | SANOFI-SYNTHELABO (FR) | 2000-02-10 | — | — | WO | disclosed |
| CN-1204258-A | Novel method | NOVO NORDISK AS (DK) | 1999-01-06 | — | — | CN | disclosed |
| EP-0869777-A1 | NOVEL METHOD | NOVO NORDISK A/S (DK) | 1998-10-14 | — | — | EP | disclosed |
| US-5795888-A | ANALGESICS, ANTIINFLAMMATORY AGENTS, ANTIDIABETIC AGENTS | NOVO NORDISK A/S (DK) | 1998-08-18 | — | — | US | disclosed |
| US-5741791-A | ADMINISTERING COMPOUNDS WHICH INHIBIT SECRETION, CIRCULATION OR EFFECT OF INSULIN ANTAGONIZING PEPTIDES; CAN BE USED TO TREAT NON-INSULIN-DEPENDENT DIABETES MELLITUS | NOVO NORDISK A/S (DK) | 1998-04-21 | — | — | US | disclosed |
| US-5721254-A | ANTIINFLAMMATORY AGENTS; ANALGESICS | NOVO NORDISK A/S (DK) | 1998-02-24 | — | — | US | disclosed |
| US-5712292-A | N-substituted azaheterocyclic carboxylic acids and esters thereof | NOVO NORDISK A/S (DK) | 1998-01-27 | — | — | US | disclosed |
| US-5693649-A | ADMINISTERING TO TREAT NEUROGENIC INFLAMMATION, MIGRAINE OR DIABETIC NEUROPATHY | NOVO NORDISK A/S (DK) | 1997-12-02 | — | — | US | disclosed |
| US-5688788-A | ANTIINFLAMMATORY, ANALGESIC | NOVO NORDISK A/S (DK) | 1997-11-18 | — | — | US | disclosed |
| US-5668129-A | ANTIINFLAMMATORY AGENTS, ANALGESICS OR ANTIDIABETIC AGENTS | NOVO NORDISK A/S (DK) | 1997-09-16 | — | — | US | disclosed |
| WO-1997022338-A1 | NOVEL METHOD | NOVO NORDISK A/S (DK) | 1997-06-26 | — | — | WO | disclosed |
| US-5595989-A | ANTIINFLAMMATORY AGENTS AND ANTIDIABETIC AGENTS | NOVO NORDISK A/S (DK) | 1997-01-21 | — | — | US | disclosed |
| EP-0738262-A1 | NOVEL HETEROCYCLIC COMPOUNDS | NOVO NORDISK A/S (DK) | 1996-10-23 | — | — | EP | disclosed |
| WO-1995018793-A1 | NOVEL HETEROCYCLIC COMPOUNDS | NOVO NORDISK A/S (DK) | 1995-07-13 | — | — | WO | disclosed |